BE642020A - - Google Patents

Info

Publication number
BE642020A
BE642020A BE642020A BE642020A BE642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A
Authority
BE
Belgium
Application number
BE642020A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE642020A publication Critical patent/BE642020A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE642020A 1962-12-31 1963-12-31 BE642020A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB49140/62A GB1027746A (en) 1962-12-31 1962-12-31 17-amino-androstane and -androstene derivatives
GB220063 1963-01-17

Publications (1)

Publication Number Publication Date
BE642020A true BE642020A (es) 1964-06-30

Family

ID=26237361

Family Applications (1)

Application Number Title Priority Date Filing Date
BE642020A BE642020A (es) 1962-12-31 1963-12-31

Country Status (5)

Country Link
BE (1) BE642020A (es)
ES (1) ES294887A1 (es)
FR (2) FR1432523A (es)
GB (1) GB1027746A (es)
NL (1) NL302932A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
ES294887A1 (es) 1964-04-16
FR1432523A (fr) 1966-03-25
FR3159M (fr) 1965-03-01
NL302932A (es)
GB1027746A (en) 1966-04-27

Similar Documents

Publication Publication Date Title
BE616548R (es)
BE626970A (es)
BE617902A (es)
BE635433A (es)
BE635049A (es)
BE612190A (es)
NL302932A (es)
BE632547A (es)
BE632276A (es)
BE632203A (es)
BE631409A (es)
BE631233A (es)
BE631013A (es)
BE630852A (es)
BE630462A (es)
BE629806A (es)
BE612464A (es)
BE616785A (es)
BE616490A (es)
BE616386A (es)
BE616166A (es)
BE615962A (es)
BE615849A (es)
BE615804A (es)
BE612311A (es)